Aspen Oss B.V.

Form 483 issued September 13, 2019 · Boxtel, Netherlands

Investigator
Guerlain Ulysse
Observations
4
Pages
4
FEI number
3010414279

In short: On September 13, 2019, FDA issued a Form 483 with 4 observations to Aspen Oss B.V. in Boxtel, Netherlands (FEI 3010414279). The investigator was Guerlain Ulysse. Most observations concern production and laboratory controls.

At a glance

Production and laboratory controls account for 3 of 4 observations.

Production2
Laboratory controls1
Quality system1

What FDA observed

Preview: the opening words of each observation

Dashed: section inferred by FDA Intel and checked against the regulation text

  1. 01

    Control procedures are not established which validate the performance of manufacturing, packaging and testing processes that…

  2. 02

    Samples taken to determine conformance to appropriate written specifications for the acceptance and identification of each…

  3. 03

    There is a failure to thoroughly review any unexplained discrepancy and the failure ofa batch or…

  4. 04

    Examination of packaging and labeling materials for suitability and correctness for packaging operations is not documented…

The full 483

Plus the full detail behind each one, exactly as FDA wrote it.

Get the full 483

This inspection in context

Questions about this 483

What did FDA find at Aspen Oss B.V.?

FDA listed 4 observations on this Form 483, mostly about production, laboratory controls and quality system. The opening words of each observation are shown on this page.

Who inspected Aspen Oss B.V.?

Guerlain Ulysse is named on this Form 483. Each investigator has a profile showing what they cite most.

When was Aspen Oss B.V. inspected by FDA?

This Form 483 is dated September 13, 2019.

How do I get the full Form 483 for Aspen Oss B.V.?

Download the original PDF from FDA Intel for $99, with no subscription. Your first Form 483 or letter is on us. You also get an invoice PDF with the order.

$99Get it free